Targeting CD28-CD86 Pathway for Refractory Myeloma Through CTLA4Ig-Based Reduced-Intensity Conditioning and Donor Lymphocyte Infusions After Haploidentical Transplantation

Publication date: Available online 30 April 2019Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Sarita Rani Jaiswal, Prakash Bhakuni, Satish Bansal, Hema Malini Aiyer, Sneh Bhargava, Suparno ChakrabartiGraphical abstract
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research